| 101 |
10754487 | Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study. | 2000 Mar 20 |
4 |
| 102 |
10898353 | Current and future directions in medical therapy for breast carcinoma: endocrine treatment. | 2000 Jun 15 |
3 |
| 103 |
10907942 | Delayed adjuvant tamoxifen: ten-year results of a collaborative randomized controlled trial in early breast cancer (TAM-02 trial) | 2000 May |
1 |
| 104 |
10945620 | Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling. | 2000 Aug 1 |
3 |
| 105 |
11051041 | Molecular markers for predicting response to tamoxifen in breast cancer patients. | 2000 Aug |
1 |
| 106 |
11056315 | Does tamoxifen change oestrogen and progesterone receptor expression in the endometrium and breast? | 2000 Sep |
1 |
| 107 |
11205227 | Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients. | 2000 Nov-Dec |
1 |
| 108 |
10053103 | Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. | 1999 Mar |
2 |
| 109 |
10542936 | Expression of steroid receptors, Ki-67, and epidermal growth factor receptor in tamoxifen-treated endometrium. | 1999 Oct |
1 |
| 110 |
9440732 | p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer. | 1998 Jan |
1 |
| 111 |
9541185 | Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with response. | 1998 Mar |
1 |
| 112 |
9598869 | Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques. | 1998 Apr |
1 |
| 113 |
9646640 | PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins. | 1998 Mar |
1 |
| 114 |
9815522 | [Tamoxifen in the treatment of patients with breast cancer: results of the latest meta-analysis of prospective randomized clinical trials]. | 1998 |
1 |
| 115 |
9024103 | Alterations in steroid hormone receptors in the tamoxifen-treated endometrium. | 1997 Jan |
1 |
| 116 |
9196144 | Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group. | 1997 Jun |
1 |
| 117 |
9345349 | Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies. | 1997 Oct |
1 |
| 118 |
8729191 | [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast]. | 1996 Mar |
2 |
| 119 |
9010319 | Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. | 1996 Nov |
2 |
| 120 |
9023387 | Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. | 1996 |
2 |
| 121 |
7563153 | Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer. | 1995 May 17 |
2 |
| 122 |
7579503 | Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation. | 1995 |
6 |
| 123 |
7614468 | Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. | 1995 Aug 1 |
4 |
| 124 |
7857700 | Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group. | 1994 |
3 |
| 125 |
7959340 | Estrogen and progesterone receptor expression of decidual endometrium in a postmenopausal woman treated with tamoxifen and megestrol acetate. | 1994 |
2 |
| 126 |
7981080 | Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer. | 1994 Dec |
1 |
| 127 |
8043492 | How do breast cancers become hormone resistant? | 1994 Jun |
1 |
| 128 |
8150773 | Estrogen receptor molecular biology. | 1994 Feb |
2 |
| 129 |
7907850 | Effects of short-term tamoxifen administration in patients with invasive cervical carcinoma. | 1993 Nov-Dec |
2 |
| 130 |
8007707 | Strategies for the application of biomarkers for risk assessment and efficacy in breast cancer chemoprevention trials. | 1993 |
2 |
| 131 |
8251648 | Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. | 1993 |
5 |
| 132 |
8291456 | Effects of tamoxifen on endometrial estrogen and progesterone receptor concentrations in women with fibrocystic disease of the breast. | 1993 Sep |
1 |
| 133 |
8347490 | Interferon plus tamoxifen treatment for advanced breast cancer: in vivo biologic effects of two growth modulators. | 1993 Aug |
2 |
| 134 |
8382104 | Up-regulation of estrogen receptor by tamoxifen in human breast cancer. | 1993 Feb 15 |
6 |
| 135 |
8439511 | Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status. | 1993 Mar |
2 |
| 136 |
8493449 | Effects of androgens on proliferation and progesterone receptor levels in T47D human breast cancer cells. | 1993 |
1 |
| 137 |
8508397 | Down-regulation of transforming growth factor-alpha by tamoxifen in human breast cancer. | 1993 Jul 1 |
1 |
| 138 |
1465279 | Variations in estrogen and progesterone receptor levels after short-term tamoxifen treatment in breast carcinoma. | 1992 |
1 |
| 139 |
1540937 | Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following downregulation of tumor progesterone receptor. | 1992 Feb 29 |
2 |
| 140 |
1591091 | Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial. | 1992 |
1 |
| 141 |
1616857 | Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line. | 1992 Jun |
1 |
| 142 |
1634918 | Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. | 1992 Aug |
4 |
| 143 |
1733196 | Both 17 beta-estradiol and tamoxifen induce c-fos messenger ribonucleic acid expression in human endometrial carcinoma grown in nude mice. | 1992 Jan |
1 |
| 144 |
1829945 | Management of male breast cancer. | 1991 Mar |
1 |
| 145 |
2050123 | Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. | 1991 Jul |
1 |
| 146 |
2123023 | Variation of estrogen and progesterone receptor status in breast cancer after tamoxifen therapy. | 1990 |
3 |
| 147 |
2255103 | Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer. | 1990 Sep |
1 |
| 148 |
2334566 | Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group. | 1990 |
1 |
| 149 |
2524460 | Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer. | 1989 Mar |
3 |
| 150 |
2526907 | Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer. | 1989 Aug |
5 |